1012 related articles for article (PubMed ID: 27580477)
21. Protective Effect of Hepatitis B Against Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease But Not in Normal Individuals.
Pei C; Wu CZ; Hsieh CH; Chang JB; Liang YJ; Chen YL; Pei D; Lin JD
Metab Syndr Relat Disord; 2019 Nov; 17(9):458-464. PubMed ID: 31545133
[No Abstract] [Full Text] [Related]
22. The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Ha Y; Hwang SG; Rim KS
Nutrients; 2017 Jul; 9(8):. PubMed ID: 28749418
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P
BMC Gastroenterol; 2022 Jul; 22(1):366. PubMed ID: 35907827
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.
Magrì S; Paduano D; Chicco F; Cingolani A; Farris C; Delogu G; Tumbarello F; Lai M; Melis A; Casula L; Fantini MC; Usai P
World J Gastroenterol; 2019 Oct; 25(37):5676-5686. PubMed ID: 31602167
[TBL] [Abstract][Full Text] [Related]
26. The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 1 diabetic patients.
Singh A; Le P; Lopez R; Alkhouri N
Hepatol Int; 2018 Jan; 12(1):37-43. PubMed ID: 29318450
[TBL] [Abstract][Full Text] [Related]
27. Overall and subgroup prevalence of non-alcoholic fatty liver disease and prevalence of advanced fibrosis in the United States: An updated national estimate in National Health and Nutrition Examination Survey (NHANES) 2011-2018.
Wang T; Xi Y; Raji A; Crutchlow M; Fernandes G; Engel SS; Zhang X
Ann Hepatol; 2024; 29(1):101154. PubMed ID: 37742743
[TBL] [Abstract][Full Text] [Related]
28. A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.
Choi SH; Oh DJ; Kwon KH; Lee JK; Koh MS; Lee JH; Kang HW
Turk J Gastroenterol; 2015 Jul; 26(4):336-43. PubMed ID: 26039004
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic.
Dvorak K; Hainer R; Petrtyl J; Zeman M; Vareka T; Zak A; Sroubkova R; Svestka T; Vitek L; Bruha R
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):442-8. PubMed ID: 25004910
[TBL] [Abstract][Full Text] [Related]
30. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
[TBL] [Abstract][Full Text] [Related]
31. The Utility of Noninvasive Scores in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Type 2 Diabetic Patients.
Singh A; Le P; Peerzada MM; Lopez R; Alkhouri N
J Clin Gastroenterol; 2018 Mar; 52(3):268-272. PubMed ID: 28787358
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
Sirota JC; McFann K; Targher G; Johnson RJ; Chonchol M; Jalal DI
Metabolism; 2013 Mar; 62(3):392-9. PubMed ID: 23036645
[TBL] [Abstract][Full Text] [Related]
33. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
[TBL] [Abstract][Full Text] [Related]
34. Relationship Between Handgrip Strength and Nonalcoholic Fatty Liver Disease: Nationwide Surveys.
Lee K
Metab Syndr Relat Disord; 2018 Nov; 16(9):497-503. PubMed ID: 30129816
[TBL] [Abstract][Full Text] [Related]
35. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.
Lucero D; Miksztowicz V; Gualano G; Longo C; Landeira G; Álvarez E; Zago V; Brites F; Berg G; Fassio E; Schreier L
Clin Chim Acta; 2017 Oct; 473():1-8. PubMed ID: 28802640
[TBL] [Abstract][Full Text] [Related]
37. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults.
Kwon YM; Oh SW; Hwang SS; Lee C; Kwon H; Chung GE
Am J Gastroenterol; 2012 Dec; 107(12):1852-8. PubMed ID: 23032980
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
39. C-peptide as a key risk factor for non-alcoholic fatty liver disease in the United States population.
Atsawarungruangkit A; Chenbhanich J; Dickstein G
World J Gastroenterol; 2018 Aug; 24(32):3663-3670. PubMed ID: 30166861
[TBL] [Abstract][Full Text] [Related]
40. Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States.
Jiang ZG; Tsugawa Y; Tapper EB; Lai M; Afdhal N; Robson SC; Mukamal KJ
Aliment Pharmacol Ther; 2015 Jul; 42(1):106-16. PubMed ID: 25913437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
